Clinical trial Recruiting at 1 site Interventional Ages 18 to 79

Low-intensity ultrasound to calm the nerves and improve sleep after heart surgery

Official title: Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases: A Multicenter, Double-Blind, Randomized Controlled Trial

Run by Renmin Hospital of Wuhan University · NCT07595068 · Data updated 2026-11-12

This trial tests whether gentle, focused ultrasound on the left stellate ganglion can improve autonomic function and sleep after heart-related surgery in adults with cardiovascular disease, compared with a sham treatment.

More Cardiovascular Diseases trials

Quick facts

Study typeInterventional
Ages18 Years to 79 Years
SexAll
Enrollment200 (estimated)
SponsorRenmin Hospital of Wuhan University
Academic / other
Locations7 sites (Huangshi, Hubei and 6 other locations)
StatusRecruiting
StartedMay 20, 2026
Main results expectedApril 1, 2027
Study endsApril 1, 2027
Registry record updatedAugust 21, 2026
Trial IDNCT07595068 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–79 with cardiovascular disease scheduled for cardiology-related surgery who consent to randomization and can tolerate the procedure.

Probably not a fit

Patients with impaired sleep or autonomic function changes not responsive to the intervention, or those unable to complete daily treatment, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, double-blind, randomized controlled trial will enroll adults with cardiovascular disease undergoing cardiology-related surgery. Participants will receive either active low-intensity focused ultrasound targeting the left stellate ganglion or a sham procedure, daily for 3–7 days, in addition to standard care. The study will assess heart rate variability, sleep quality, serological markers, vital signs, and perioperative arrhythmias, with safety monitored closely. The design includes blinding of participants, operators, assessors, and analysts to minimize bias. The trial is led by Renmin Hospital of Wuhan University with several collaborating centers in Hubei province and is expected to begin in May 2026.

Why it matters

Potential benefit: If successful, patients may experience better autonomic regulation and sleep after surgery, potentially improving recovery after cardiovascular procedures.

How similar studies have gone: Prior studies in related neuromodulation approaches have shown signals of autonomic and sleep effects, but this exact LIFU stellate ganglion method in perioperative CVD patients is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Diagnosed with cardiovascular disease (CVD) and scheduled to undergo cardiology-related surgical treatment
2. Able to receive and tolerate the aforementioned cardiology-related surgical treatment
3. Aged between 18 and 79 years (inclusive), with no restriction on gender
4. Agree to accept random allocation of the treatment strategies
5. With clear consciousness, no severe mental disorders or cognitive impairment; voluntarily sign the written informed consent form (ICF) and are willing to actively cooperate with the study treatment

Exclusion Criteria:

1. Have used sedative-hypnotic drugs, antipsychotic drugs, opioid analgesics, antihistamines, non-steroidal anti-inflammatory drugs (NSAIDs), central nervous system (CNS) stimulant drugs, or any other medications that alter sleep architecture within the past 30 days
2. Have a history of cervical infection, trauma, severe cervical deformity, or prior cervical surgery
3. Unable to complete the daily study intervention as required by the trial protocol
4. Are participating in another clinical trial, or have participated in other clinical trials with interventions that may interfere with the results of this study
5. Have undergone major surgery or general anesthesia within the past 30 days
6. Have a history of alcohol abuse
7. Are female subjects who are pregnant or lactating, or plan to become pregnant during the study period
8. Have severe cognitive impairment, severe psychiatric disorders, epilepsy, or other related neurological disorders
9. Have concomitant malignant tumor or severe dysfunction of vital organs
10. Have active systemic infection
11. Have significant bleeding tendency, or renal failure undergoing regular hemodialysis
12. Are deemed unsuitable for the trial by the investigator for any other reason -

Where it's running

  • Renmin Hospital of Wuhan University
    Wuhan, Hubei, China
    Recruiting
  • Huangshi Central Hospital
    Huangshi, Hubei, China
    Not yet recruiting
  • Jingzhou Central Hospital
    Jingzhou, Hubei, China
    Not yet recruiting
  • Wuhan Central Hospital
    Wuhan, Hubei, China
    Not yet recruiting
  • Wuhan Third Hospital
    Wuhan, Hubei, China
    Not yet recruiting
  • Xiangyang Central Hospital
    Xiangyang, Hubei, China
    Not yet recruiting
Show 1 more location
  • Yichang Central People's Hospital
    Yichang, Hubei, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.